Awakn Life Sciences Corp (AWKNF PINK) stock market data APIs
$0.0644
0.01(15.5%)
as of May 2, 2025
Awakn Life Sciences Corp Financial Data Overview
Awakn Life Sciences Corp., a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisting of racemic ketamine, delivered intravenously, and manualized relapse prevention cognitive behavioural therapy (CBT) which is in phase 3 trials to treat severe Alcohol Use Disorder (AUD); AWKN-002, a novel MAT consisting of a patent pending proprietary S"ketamine oral thin film, and manualized relapse prevention CBT to treat AUD; and MDMA/Zydis, an investigational medicinal product entactogen that acts as a releaser and reuptake inhibitor of serotonin, norepinephrine, and dopamine. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD; with Graft Polymer (UK) PLC to develop chemical entity series programme for trauma-related mental health disorders; and with the University of Nottingham focusing on evaluating the company's lead aminoindane series and its potential to enhance social cognition and pro-social behaviors. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.
Prev. Close
0.0644
Open
0.0793
High
0.0851
Low
0.0644
52 wk Range
0.055-0.18
Market Cap
2 742 K
Shares Outstanding
41 663 K
Revenue
57 161
EPS
-0.0079
Beta
2.608
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Awakn Life Sciences Corp data using free add-ons & libraries
Get Awakn Life Sciences Corp Fundamental Data
{
"General": {
"Code": "AWKNF",
"Type": "Common Stock",
"Name": "Awakn Life Sciences Corp",
"Exchange": "PINK",
"CurrencyCode": "USD",
"CurrencyName": "US Dollar",
"CurrencySymbol": "$",
"CountryName": "USA",
"CountryISO": "US",
"OpenFigi": "BBG011XYP356",
"ISIN": null,
"CUSIP": null,
"CIK": "0001948724",
"EmployerIdNumber": null,
"FiscalYearEnd": "January",
"IPODate": null,
"InternationalDomestic": null,
"Sector": "Healthcare",
"Industry": "Biotechnology",
"HomeCategory": null,
"IsDelisted": false,
"Description": "Awakn Life Sciences Corp., a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisti..."
}
}Awakn Life Sciences Corp Fundamental data includes:
- Net Revenue: 57 161
- EBITDA: -2 402 206
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Awakn Life Sciences Corp News
New
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Hydrofarm sales are still declining, despite improved revenue projections. Agrify announced a modification to their credit agreement with Bridge Bank. Trulieve announce...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Green Thumb will have a conference call to discuss its Q4 and full 2022 earnings on February 28, 2023. High Tide Q4 revenue rose 14% to C$108 million. SNDL completed th...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector 22nd Century announced partnerships with Core-Mark and Eby-Brown, two of the largest U.S. convenience store distributors. Scotts Miracle-Gro announced timing for Q1 fin...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Leafly Holdings started the year with strong market performance. Innovative Industrial Properties’ market performance remained robust, following the announcement of s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
